Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

At NHS Lothian, High-Throughput NxTAG® RPP Streamlines Respiratory Testing

Test replaced LDT, offering better ease of use and more comprehensive targets

At the Royal Infirmary of Edinburgh Clinical Virology Department, respiratory testing can be a full-time task. As part of the NHS Lothian Laboratory Medicine, the group covers all aspects of viral testing for Edinburgh and surrounding areas, and also serves as a referral lab for other regions of Scotland. The lab receives a total of 100,000 samples and runs 1 million tests per year, with approximately 30,000 of those samples involving respiratory assays.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

Like many labs, @CedarsSinai microbiology sees extreme seasonal fluctuations in testing demands - from 90 #flu &…
h J R
In the race against resistance, the speed of diagnosis can make all the difference. Sherry Dunbar talks to…
h J R
RT @CDCFlu: CDC estimates that as of January 12, there have been up to 114,000 flu-related hospitalizations this #fluseason. Join us. Take…
h J R

Latest News

January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results

October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio

October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018

September 11
Luminex Corporation Declares Third Quarter Cash Dividend


xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands